Dialysis Initiation for an Incapacitated Patient Authors: Kathleen McFadden, Emily Rubin, Meghan Sise Published: 2026 Introduction Incapacitated patients are frequently hospitalized with complex illness, often necessitating urgent decisions regarding the initiation of life support including kidney replacement therapy (KRT). Many have a previously selected health care decision maker, (i.e., health care proxy [HCP]) and others require a health care decision maker determined by national or state-specific next-of-kin laws. Those without an appointed or available default decision maker often undergo a legal process by which a guardian is appointed to make decisions on their behalf (Table 1). In such cases, recognizing incapacity may be limited or more permanent, nephrologists must work acutely to uphold shared decision-making standards in collaboration with available surrogate decision makers. Here, we present ethical frameworks to guide nephrologists in these decisions.Table 1Teaching pointsSurrogate medical decision-making authority varies widely by location; some jurisdictions have default next-of-kin laws for incapacitated patients. Other states require legally appointed guardians for incapacitated patients who do not have an appointed surrogate. It is important to understand the local laws relevant to this when making decisions regarding kidney replacement therapy for incapacitated patients.Self-appointed surrogate decision makers (i.e., health care proxy, health care power of attorney) are typically closely acquainted with a patient and often feel comfortable speaking to an incapacitated patient’s wishes using substituted judgment. A court-appointed, non-familial legal guardian may have less longitudinal knowledge of the patient and thus be less certain of the patient’s wishes regarding a care decision not previously queried.In situations of clinical acuity with an incapacitated patient, standardized frameworks for ethical decision making, including but not limited to substituted judgment, principlism, and the best interest standard, can guide a nephrologist in presenting clinically sound and ethically appropriate treatment options. Table 1Teaching pointsSurrogate medical decision-making authority varies widely by location; some jurisdictions have default next-of-kin laws for incapacitated patients. Other states require legally appointed guardians for incapacitated patients who do not have an appointed surrogate. It is important to understand the local laws relevant to this when making decisions regarding kidney replacement therapy for incapacitated patients.Self-appointed surrogate decision makers (i.e., health care proxy, health care power of attorney) are typically closely acquainted with a patient and often feel comfortable speaking to an incapacitated patient’s wishes using substituted judgment. A court-appointed, non-familial legal guardian may have less longitudinal knowledge of the patient and thus be less certain of the patient’s wishes regarding a care decision not previously queried.In situations of clinical acuity with an incapacitated patient, standardized frameworks for ethical decision making, including but not limited to substituted judgment, principlism, and the best interest standard, can guide a nephrologist in presenting clinically sound and ethically appropriate treatment options. Teaching points We use the case of a patient without decision making capacity who had previously elected a HCP to illustrate how nephrologists can guide ethical decision-making around initiation of KRT and to contrast the differences between the path to surrogate medical decision making when a patient-appointed surrogate versus a legally appointed guardian must make medical decisions. Case Presentation A 72-year-old man with a history of hypertension, a previous stroke resulting in mild expressive aphasia, and a recently-discovered 5.5 cm renal mass with no evidence of metastatic disease, but likely renal cell carcinoma (for which the patient had declined further evaluation) presented to the hospital from home with septic shock from pneumonia and acute gallstone related cholangitis requiring urgent percutaneous cholecystostomy tube placement. He rapidly developed oligoanuric acute kidney injury and a hemodynamically significant upper gastrointestinal bleed requiring 10 units of red blood cell transfusion. Because of respiratory failure requiring intubation and hypoactive delirium, the patient lacked decisional capacity. The patient’s legal medical decision-maker was his self-appointed HCP—his brother—who noted that consideration of KRT had never been discussed given he lacked advanced chronic kidney disease. In the goals of care discussion, his brother was confident the patient would not want life-long KRT because of previous avoidance of medical interventions and a known strong preference to avoid routine interactions with the health care system, but the proxy struggled with the uncertainty regarding whether KRT would be temporary or permanent, particularly noting a desire to give the patient every possible chance of recovery to his previous functional status which had been robustly independent. Although acute, life-saving interventions were goal-concordant, there was significant hesitancy to initiate a path that would change the patient’s life-long, outpatient trajectory. Relevant Laboratory Results and/or Response to Treatment During intensive care unit admission, the patient’s acute kidney injury progressed and he developed uremic encephalopathy (blood urea nitrogen 151 mg/dl, serum creatinine 10.1 mg/dl), metabolic acidosis (serum bicarbonate of 11 mmol/l, pH 7.3), and hyperkalemia (5.4 mEq/l). His nephrology team felt that his baseline creatinine of 1.4 mg/dl, improving hemodynamics, and contribution of iodinated contrast to his acute kidney injury portended a favorable chance of kidney recovery after temporary KRT. The patient was initiated on firmly defined, 1-week trial of KRT after extensive discussion with the HCP. During the week that the patient received KRT, his mental status improved, urine output improved, and he recovered to his baseline. He was discharged home off dialysis after a 2.5-week hospitalization with a discharge creatinine of 2.4 mg/dl which continued to recover. Discussion Up to 50% of medical inpatients experience decisional incapacity.1 Nephrologists play a critical role in navigating the ethical consideration of KRT for incapacitated patients. In our case, the patient’s medical decision maker was guided by the principle of substituted judgment (Table 2),2, 3, 4, 5 through which the patient’s previous preferences and interactions with the health care system were used to inform care in the setting of incapacity, regarding an intervention that was never discussed. The patient’s desire to minimize interactions with the health care system and to live independently informed discussions surrounding limiting the duration of KRT to 1 week.Table 2Frameworks for ethical decision makingEthical framework or principleDefinitionLimitations of this approachExample application of how the principal would inform the KRT decision for this patientPrinciplismRelies on the Belmont principles to make medical decisions based on 4 key values: autonomy, beneficence, non-maleficence, and justice.2 Decisions which most clearly respect these values are seen as the most ethically permissible with a heightened importance placed on autonomy in the US.No clear ethical prioritization when there is conflict between values (i.e., when what a patient wishes and what is considered most beneficial are not the same). US ethics prioritize patient autonomy; this may be challenging to uphold in cases where patients are under guardianship and by default presumed to lack decision making capacity, though some patients under guardianship able to still endorse preferences to some extent.“Based on the patient’s previously stated wishes regarding life-sustaining care for an acute illness and that short-term dialysis will be of immediate benefit greater than burden, we recommend initiating a time-limited trial of KRT to begin urgently to address uremia.”DeontologicalEthical approach focused on duty, responsibility, and a particular focus on truth telling. Patient autonomy is secondary to a physician upholding their perceived innate obligations.3Approach may deprioritize patient suffering and clinical outcomes in preference for a rigid focus on what is “right”. The “right” decision is driven clinician perceptions of their moral duty to produce the best outcome. This approach may focus of life-prolongation without specific guidance on “rightness” other than one’s perceived obligation. This can lead to morally/ethically acceptable decisions that have the potential to be insensitive or clinically harmful“It is our duty to prioritize life-preservation and to honor the patient’s previous wishes for maximalist care of acute illness. Thus, we should immediately initiate KRT.”Best InterestDecisions are made based on presumption of what is best for the patient’s overall welfare, including physical and psychosocial wellbeing. When used appropriately, this also integrates the values a patient’s surrogate provides such that providers can integrate this into a clinical recommendation. This is a value-based judgment made by providers or stakeholders when a patient’s historic wishes are unknown.This can be a highly subjective approach to decision making by which value-based judgments can be made by providers regarding an acceptable quality of life on behalf of a vulnerable patient. This is the most paternalistic approach to ethical decision making.4“Because the patient has untreated cancer and given the presence of severe infection, within the context of previous goals of care conversations to avoid frequent health care interventions, dialysis would not be in the patient’s best interest, and we recommend against KRT initiation.”Substituted JudgmentEthical approach through which collateral is obtained about a patient to understand the “then-self”, that is who the person was when they had capacity. This is then extrapolated to the decision at hand to determine “if the patient were still their capacitated self, which decision would they historically have made” with the goal of preserving patient autonomy.This approach is based in the assumption that persons and perspectives do not change. It may also be challenging to separate a presumption of what a patient would have wanted from what the decision maker or health care proxy desires the outcome to be.5“Given the patient’s previous refusal of invasive medical care and their life-long preference to avoid any frequent contact with doctors, we believe that if they could make this decision for themselves, they would not want life-long KRT and thus we recommend either a time-limited trial of KRT or support non-initiation of KRT.KRT, kidney replacement therapy. Table 2Frameworks for ethical decision makingEthical framework or principleDefinitionLimitations of this approachExample application of how the principal would inform the KRT decision for this patientPrinciplismRelies on the Belmont principles to make medical decisions based on 4 key values: autonomy, beneficence, non-maleficence, and justice.2 Decisions which most clearly respect these values are seen as the most ethically permissible with a heightened importance placed on autonomy in the US.No clear ethical prioritization when there is conflict between values (i.e., when what a patient wishes and what is considered most beneficial are not the same). US ethics prioritize patient autonomy; this may be challenging to uphold in cases where patients are under guardianship and by default presumed to lack decision making capacity, though some patients under guardianship able to still endorse preferences to some extent.“Based on the patient’s previously stated wishes regarding life-sustaining care for an acute illness and that short-term dialysis will be of immediate benefit greater than burden, we recommend initiating a time-limited trial of KRT to begin urgently to address uremia.”DeontologicalEthical approach focused on duty, responsibility, and a particular focus on truth telling. Patient autonomy is secondary to a physician upholding their perceived innate obligations.3Approach may deprioritize patient suffering and clinical outcomes in preference for a rigid focus on what is “right”. The “right” decision is driven clinician perceptions of their moral duty to produce the best outcome. This approach may focus of life-prolongation without specific guidance on “rightness” other than one’s perceived obligation. This can lead to morally/ethically acceptable decisions that have the potential to be insensitive or clinically harmful“It is our duty to prioritize life-preservation and to honor the patient’s previous wishes for maximalist care of acute illness. Thus, we should immediately initiate KRT.”Best InterestDecisions are made based on presumption of what is best for the patient’s overall welfare, including physical and psychosocial wellbeing. When used appropriately, this also integrates the values a patient’s surrogate provides such that providers can integrate this into a clinical recommendation. This is a value-based judgment made by providers or stakeholders when a patient’s historic wishes are unknown.This can be a highly subjective approach to decision making by which value-based judgments can be made by providers regarding an acceptable quality of life on behalf of a vulnerable patient. This is the most paternalistic approach to ethical decision making.4“Because the patient has untreated cancer and given the presence of severe infection, within the context of previous goals of care conversations to avoid frequent health care interventions, dialysis would not be in the patient’s best interest, and we recommend against KRT initiation.”Substituted JudgmentEthical approach through which collateral is obtained about a patient to understand the “then-self”, that is who the person was when they had capacity. This is then extrapolated to the decision at hand to determine “if the patient were still their capacitated self, which decision would they historically have made” with the goal of preserving patient autonomy.This approach is based in the assumption that persons and perspectives do not change. It may also be challenging to separate a presumption of what a patient would have wanted from what the decision maker or health care proxy desires the outcome to be.5“Given the patient’s previous refusal of invasive medical care and their life-long preference to avoid any frequent contact with doctors, we believe that if they could make this decision for themselves, they would not want life-long KRT and thus we recommend either a time-limited trial of KRT or support non-initiation of KRT.KRT, kidney replacement therapy. Frameworks for ethical decision making KRT, kidney replacement therapy. Although this process was readily achieved with a previously designated HCP, placing limits on medical interventions and achieving goal-concordant care can be significantly more challenging in patients who have a court-appointed, nonfamilial legal guardian. Although a family member or acquaintance can serve as a guardian, more often a guardian is a court-appointed representative who does not have close, longitudinal ties to help inform the patient’s preferences or historic wishes.6 In 2023, it was estimated that 1.3 million US adults were under legal guardianship, the majority of these being older or otherwise disabled individuals.7 As the population ages, reliance on guardian-driven decision making will increase, particularly in regions that have not established default legal paths to surrogate decision making. In the US, some states have laws which stipulate decision making hierarchies through next-of-kin, which is often a spouse, parent, or child. In other states, that is Massachusetts or New York, “next-of-kin” do not automatically have medical decision-making authority, and a legal process often must be initiated to establish a legally binding medical decision maker. There is also significant international variability to these laws. Notably, once a patient is under guardianship, further legal proceedings are often necessary for the guardian to elect limitations on life-sustaining care. For example, a guardian often cannot legally change code status from full code to do not resuscitate without court authority, even if this is the recommendation of the clinical team. This practice ensures careful protection of potentially under-represented patients but leads to a maximalist care approach which may be clinically inadvisable. This places patients with legal guardians at risk of being subjected to a default path of maximalist acute medical care while lengthy court processes evolve. Navigating decision making frameworks is further complicated by the complexity of terminology, significant variability in decision making authority for guardians, and limited clinician education on these nuances. These cases reveal tension between ethically permissible care and default legal processes for maximalist care, culminating with ethical dilemmas. However, the core ethical principles of autonomy, beneficence, and justice still apply to patients under guardianship. Absent longitudinal information on the patient’s preferences or wishes and given the limitations of a court-based system, it can be difficult both to predict what a patient may have wanted and to protect them from unintended harm. There are certainly patients under legal guardianship who benefit from the acute initiation of KRT, and an individualized approach is required. Team-based, collaborative clinical decision making to place the decision regarding KRT into the global trajectory of illness is also imperative. Guardians typically do not have a medical background and will rely on the nephrologist to provide honest insight into what quality of life can be achieved, what the chance of renal recovery is, and what the most reasonable path forward may be. Regardless of who a patient’s surrogate decision maker is, inpatient nephrology teams can use ethical frameworks to help guide informed, ethically sound decisions regarding KRT initiation. In these cases, a focus on principlism, and considering the patient’s autonomy, making every effort to apply substituted judgment by understanding the patient’s historic wishes, and understanding the benefits and limitations of applying the best interest standard, may guide nephrologists in the acute setting (Table 2). A nephrologist facing a challenging clinical decision for an incapacitated patient should consider these frameworks but also involve hospital ethics, palliative care, and social work teams for further guidance in these complex cases. The case described above highlights the importance of applying ethical frameworks in the setting of decisional incapacity. If offering a time-limited trial of KRT, it is important to explicitly state plans for de-escalation and a predefined duration of KRT. In this case, because of the acute etiology and the certainty his decision-maker felt about his long-term wishes, a week was the maximum amount of time on dialysis that his family deemed permissible. Determining the length of a dialysis trial can feel arbitrary but ideally should take into consideration a clinical timeline of expected improvement or decline (i.e., more than 1 week trial may be advised in other cases) and should be framed in the context of permissible, nonburdensome care for the patient. It is equally as important to deliberately consider the wisdom of offering KRT in certain clinical scenarios as outlined by national and international recommendations.8,9 Future efforts in the field should focus on improving serious illness communication training, practical tools for capacity assessment, and better education on local laws surrounding surrogate decision-making. In doing so, nephrologists will be better able to apply substituted judgment while engaging in shared decision-making to ensure that kidney care is being offered in a manner that is medically reasonable and goal concordant. Disclosure MS declares research funding from Otsuka, Gilead, Cabaletta, Novartis, Roche/Genetech, Merck, Amgen, AstraZeneca. Has served on Scientific advisory boards or had scientific consulting agreements with Vera, Travere, Novartis, Biogen, Otsuka, Relay TX, Merida Biosciences, Invivyd, MediBeacon, Infectious Diseases Society of America, and is a data safety monitoring committee member for Alpine Immune Sciences/Vertex. Paid Editorial team member for NEJM Clinician and Kidney International Reports. Speaker fees Medintelligence/Reach MD, Curio Sciences, TD Cowen. The other authors declared no competing interests. Patient Consent The authors declare that they have obtained consent from the patients discussed in the report.